Livatag(R) shows significant survival increase in advanced hepatocellular carcinoma patients
er_sandeep
Member Posts: 5
Read this article today about Livatg which says that it extends survival benefits to 32 month in comparison of current 17 months.
Can some one suggest about it.
http://www.businesswire.com/news/home/20110627006456/en/BioAlliance-Pharma-Submits-Phase-III-Clinical-Trial
Can some one suggest about it.
http://www.businesswire.com/news/home/20110627006456/en/BioAlliance-Pharma-Submits-Phase-III-Clinical-Trial
0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.9K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 398 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 671 Leukemia
- 794 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 238 Multiple Myeloma
- 7.1K Ovarian Cancer
- 63 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 540 Sarcoma
- 734 Skin Cancer
- 654 Stomach Cancer
- 192 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards